Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.320
+0.140 (6.42%)
At close: Jun 5, 2025
6.42%
Market Cap 1.48B
Revenue (ttm) 666.58M
Net Income (ttm) 97.53M
Shares Out 671.34M
EPS (ttm) 0.15
PE Ratio 15.15
Forward PE n/a
Dividend 0.02 (0.93%)
Ex-Dividend Date Sep 25, 2025
Volume 611,650
Average Volume 241,357
Open 2.195
Previous Close 2.180
Day's Range 2.195 - 2.330
52-Week Range 1.750 - 3.440
Beta 0.12
RSI 70.33
Earnings Date Aug 14, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are av... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,357
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.

Financial Statements

News

There is no news available yet.